Quick Answer
Greenwich LifeSciences, Inc. reported Shares Outstanding of 13.15 million shares for fiscal year 2024.
Greenwich LifeSciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 13.15M | +2.4% |
| 2023 | 12.85M | +0.0% |
| 2022 | 12.85M | -2.3% |
| 2021 | 13.15M | +3.5% |
| 2020 | 12.70M | +50.2% |
| 2019 | 8.46M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 13.79M | +4.9% | +2.4% |
| June 30, 2025 | 13.47M | +3.1% | +2.1% |
| March 31, 2025 | 13.19M | +2.5% | +0.3% |
| December 31, 2024 | 13.15M | +2.4% | +0.1% |
| September 30, 2024 | 13.14M | +2.3% | +0.6% |
| June 30, 2024 | 13.07M | +1.7% | +1.5% |
| March 31, 2024 | 12.88M | +0.2% | +0.2% |
| December 31, 2023 | 12.85M | +0.0% | +0.0% |
- Greenwich LifeSciences, Inc. showed an increase of +2.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2024 period, Greenwich LifeSciences, Inc.’s shares outstanding has grown by 55.5% (from 8.46 million shares to 13.15 million shares).
- The most recent figure is from Greenwich LifeSciences, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: